SNTI: רווח נקי למניה (EPS TTM) Senti Bio

Senti Biosciences, Inc. (SNTI) relies on stable biotech demand that remains independent of macroeconomic factors, while maintaining strict eco-ethics and data cybersecurity. The current annual net income per share filters out market noise, with the value of -1.77 expressing the metric level. This price action confirms the success of the US-based operation in creating gene circuits for the targeted destruction of cancer cells.

Bioprocess robotization at Senti Biosciences, Inc. (SNTI) reduces costs, directly impacting bottom-line profitability. This metric measures the portion of net income attributable to a single common share, excluding the influence of the total issuance volume. Investors utilize this filter to assess the operational efficiency of capital amid limited liquidity. Positive dynamics confirm the business's financial stability. By analyzing net income per share over the last 12 months, one can timely identify the trend reversal point.